A randomized controlled study of postoperative adjuvant chemotherapy of UFT compared with surgery alone for serosa-negative advanced gastric cancer (NSAS-GC)

Trial Profile

A randomized controlled study of postoperative adjuvant chemotherapy of UFT compared with surgery alone for serosa-negative advanced gastric cancer (NSAS-GC)

Completed
Phase of Trial: Phase III

Latest Information Update: 19 May 2016

At a glance

  • Drugs Tegafur/uracil (Primary)
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Sponsors Taiho Pharmaceutical
  • Most Recent Events

    • 07 Jul 2008 Actual completion date Aug 2007 added as reported by ClinicalTrials.gov.
    • 07 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 20 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top